Resources Top 5: Renowned investor Eric Sprott gives thumbs up to silver strategy of RCM
Resources Rising Stars: Four up-and-comers under $100m ready to shine
How to buy investment properties without spending a cent
Health Check: After raising up to $14m, Emvision is off and running with its Emu stroke detection push
Resources Rising Stars: Tailwinds forming for mid and small caps with ‘risk appetite back’
Lunch Wrap: BHP swings the axe; Droneshield keeps buzzing
Greenvale Energy outlines continuous uranium mineralisation at Oasis
The financial knowledge gap: Why Gen Z ambition could fall short without guidance
Strategic reserves and supply shortages – uranium’s future glows brighter
Biocurious: Noxopharm has the ‘burning fire’ of inflammation squarely in its sights
Contributors
Our Resident Experts
Mining
Resources Rising Stars: Four up-and-comers under $100m ready to shine
Resources Rising Stars: Tailwinds forming for mid and small caps with ‘risk appetite back’
Strategic reserves and supply shortages – uranium’s future glows brighter
Greenland’s riches tickle fancy of US but Australians have key to success
Gold Rush: New investors flock to Magmatic Resources after Weebo acquisition
Featured in Mining
Tech
Health & Biotech
Biocurious: Noxopharm has the ‘burning fire’ of inflammation squarely in its sights
Health Check: CSL plucks up Dutch courage with R&D partnership worth about $755m
‘Tough nut to crack’, but expert tips Alterity’s MSA drug as potential game changer
Health Check: At risk of third ‘strike’, Clinuvel argues its executive pay is ‘appropriate’
Scott Power: ASX health stocks remain under pressure but Telix charts FDA path forward
Featured in Health & Biotech
Experts
Stock Tips: A big bank, fintech, packaging and pizza resonate this week
Criterion: The rice and rice of an overlooked agri powehouse
AI fever pushes markets to extremes but investors must keep nerve
ASX Small Caps Weekly Form Guide
The generational investment divide threatening family wealth
Why government help may be setting up first-home buyers for failure
Alternative assets: Which investments soared and which crashed?
